Valeant Pharmaceuticals International (VRX) · page 44 of 47
The slide uses a bridge framework to reconcile 2015 revenue to 2020 estimates for cliff products.
Conference presentation · valuation_table · show_valuation_bridge · dense density
Slide locked Sign in to view
Slide schematic 5/5
source-note 1/1 table 3/3 title 1/1
Components 5
source-note data data valuation headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1